RecruitingNot Applicable

A Clinical Trial to Compare Lasotronix Alone or in Combination With CPP-ACP to Treat DH

Pakistan120 participantsStarted 2024-05-12

Plain-language summary

Dentin hypersensitivity (DH) is defined as sharp pain of a shorter duration arise from exposed dentin in response to several chemicals and thermal or tactile stimuli that cannot be ascribed to other dental defects". DH has a prevalence rate ranging from 1.3% to 92.1%, commonly affecting old ages. The use of laser has opened new dimensions in the treatment of DH. To the author's knowledge, not much research work has been conducted using LASOTRONIX as a treatment modality with CPP-ACP. Therefore, this research aims to determine the effectiveness of Casein phospho peptide paste (CPP-ACP) used alone or combined with a diode laser (LASOTRONIX).

Who can participate

Age range25 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria: * Patients of either gender, with ages between 25-65 years * should have at least more than one hypersensitive and vital tooth without any carious lesion or defective restoration Exclusion criteria: * History of desensitizing therapy on the affected tooth/teeth in last six months (use of desensitizing toothpaste) * use of antibiotics /analgesic/anti-inflammatory drugs * history of smoking * pregnancy * those who are not willing to participate or give follow-ups

What they're measuring

treatment of dentin hypersensitivity

Timeframe: 0-3 moths

Trial details

NCT IDNCT06463938

SponsorDow University of Health Sciences

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-08-10

Contact for this trial

Sanam Dr Faheem, MSc

021-38771000 sanam.faheem@duhs.edu.pk

View on ClinicalTrials.gov More Dentin Sensitivity trials